FDA Issues Warnings Regarding Xeljanz (tofacitinib)
On July 26, the U.S. Food and Drug Administration (FDA) approved new warnings of an increased chance of blood clots...
Learn MoreChilders, Schlueter & Smith, LLC
On July 26, the U.S. Food and Drug Administration (FDA) approved new warnings of an increased chance of blood clots...
Learn More